share_log

三生製藥:截至2024年12月31日止月份之股份發行人的證券變動月報表

3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

HKEX ·  Jan 2 00:40

Summary by Moomoo AI

三生制藥於2025年1月2日發布2024年12月份證券變動月報表。報告顯示,公司於當月註銷了21,227,000股庫存股份,使得已發行股份總數從2,416,800,912股減少至2,395,573,912股。公司的法定股本保持不變,仍為5億美元,由500億股每股面值0.00001美元的普通股組成。此外,公司的購股權計劃下仍有16,486,000份未行使的期權,行使價為每股7.62港元。這次庫存股份的註銷反映了公司對股本結構的調整,可能旨在優化股權結構或提升每股價值。然而,具體原因及對公司未來發展的影響,需要進一步的公司聲明或財務報告來評估。
三生制藥於2025年1月2日發布2024年12月份證券變動月報表。報告顯示,公司於當月註銷了21,227,000股庫存股份,使得已發行股份總數從2,416,800,912股減少至2,395,573,912股。公司的法定股本保持不變,仍為5億美元,由500億股每股面值0.00001美元的普通股組成。此外,公司的購股權計劃下仍有16,486,000份未行使的期權,行使價為每股7.62港元。這次庫存股份的註銷反映了公司對股本結構的調整,可能旨在優化股權結構或提升每股價值。然而,具體原因及對公司未來發展的影響,需要進一步的公司聲明或財務報告來評估。
Sanjin Pharmaceutical released the monthly securities changes report for December 2024 on January 2, 2025. The report shows that the company canceled 21,227,000 treasury shares during the month, reducing the total number of issued shares from 2,416,800,912 to 2,395,573,912 shares.The company's legal capital remains unchanged at 0.5 billion USD, consisting of 50 billion shares of common stock with a par value of 0.00001 USD per share. In addition, there are still 16,486,000 unexercised Options under the company's stock option plan, with an exercise price of HKD 7.62 per share.The cancellation of these treasury shares reflects the company's adjustment of its equity structure, which may aim to optimize the equity structure or enhance the value per share. However, the specific reasons and the impact on the company's future development need to be evaluated further based on additional company statements or financial reports.
Sanjin Pharmaceutical released the monthly securities changes report for December 2024 on January 2, 2025. The report shows that the company canceled 21,227,000 treasury shares during the month, reducing the total number of issued shares from 2,416,800,912 to 2,395,573,912 shares.The company's legal capital remains unchanged at 0.5 billion USD, consisting of 50 billion shares of common stock with a par value of 0.00001 USD per share. In addition, there are still 16,486,000 unexercised Options under the company's stock option plan, with an exercise price of HKD 7.62 per share.The cancellation of these treasury shares reflects the company's adjustment of its equity structure, which may aim to optimize the equity structure or enhance the value per share. However, the specific reasons and the impact on the company's future development need to be evaluated further based on additional company statements or financial reports.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more